Necrotizing Gingivostomatitis Treatment Market Trends

  • Report ID: 3570
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Necrotizing Gingivostomatitis Treatment Market Trends

Growth Drivers

  • Increasing Incidences of Necrotizing Gingivostomatitis across the Globe – Gingivostomatitis is a regular mouth infection with symptoms of mouth and gum swelling. It is most common in children and is caused by herpes simplex virus type 1, coxsackievirus, poor oral hygiene, and by bacteria such as Streptococcus, and Actinomyces. Unhygienic health habits such as not brushing teeth and flossing are estimated to increase the occurrence of the disease thereby rising the market demand. The children are more prone to get the disease as they do not like to brush their teeth and parents need to be strict in maintaining the oral hygiene of their children. More than 0.4% to 10% of the population around the globe are affected by trench mouth or necrotizing gingivostomatitis and are around the age of 18 to 20 years as per the 2022 reports.
  • Poor Lifestyle and Weak Immunity of the People Suffering from Immune Suppressive Disorders – The percentage of people suffering from autoimmune diseases was estimated to be between over 4% to 7% in the U.S. as per the estimations of 2023.
  • Unhygienic Habits such as Not Washing Mouth Flossing Every Day – It was noted that worldwide more than 56% of people do not use floss and over 45% of people only floss once a week as of 2020 reports.
  • Increasing Use of Public Toilets Across the World with Increasing Travelling Rate – It is reported that in 2019, more than 58% of American residents used public restrooms or toilets a minimum of one to five times a week.
  • Increasing Number of People not Washing Their Hands After Using Bathroom – In 2020, more than 8% of people in the U.S. reported that they wash their hands once in a while and more than 3% of people do not wash their hands after using the washroom.

Challenges

  • Circulation of Generic Drugs as They are Cost Efficient
  • High Rate of Side Effects from Antibiotics Use – The increasing use of side effects of antibiotics includes rash, dizziness, diarrhea, nausea, and yeast infections. Also, other serious side effects include Clostridioides difficile infection that leads to diarrhea and severe colon damage, and eventually death. These side effects of medications are estimated to hamper the market growth in the coming years.
  • Increasing Home Care Treatments Across the World

Necrotizing Gingivostomatitis Treatment Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

6.6%

Base Year Market Size (2023)

USD 15.99 Million

Forecast Year Market Size (2036)

USD 36.7 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3570
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of necrotizing gingivostomatitis treatment is estimated at USD 16.94 Million.

The necrotizing gingivostomatitis treatment market size was valued at USD 15.99 Million in 2023 and is anticipated to cross USD 36.7 Million by the end of 2036, expanding at more than 6.6% CAGR during the forecast period i.e., between 2024-2036. Increasing incidences of necrotizing gingivostomatitis and the rising use of public toilets are the major factors driving the market growth.

North America is poised to be the largest with a share of about 39% by 2036, attributed to high prevalence of lifestyle diseases, caused by inactive routines, busy lifestyles, and unhealthy eating habits.

Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited, Aviro Health L.P.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample